Capricor Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QNov. 10, 2026, 5:25 p.m. ETView on SEC.gov
8-KNov. 10, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedCapricor Therapeutics Q3 2026 EPS of -$0.73 Misses -$0.41 Consensus; Zero Revenue Against $10.4 Million Expected
SCHEDULE 13G/AOct. 14, 2026, 5:14 p.m. ETView on SEC.gov
SCHEDULE 13GSept. 14, 2026, 6:53 p.m. ETView on SEC.gov
8-KAug. 24, 2026, 9:25 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits
SCHEDULE 13GAug. 19, 2026, 7:07 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:15 p.m. ETView on SEC.gov
10-QAug. 14, 2026, 4:46 p.m. ETView on SEC.gov
8-KAug. 13, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
SCHEDULE 13GAug. 7, 2026, 8:54 a.m. ETView on SEC.gov
SCHEDULE 13GAug. 3, 2026, 4:36 p.m. ETView on SEC.gov
8-KJuly 30, 2026, 4:05 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KJuly 29, 2026, 10:05 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits